Motus GI is a medical technology company with subsidiaries in the U.S. and Israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The Company is focused on the development and commercialization of the Pure-Vu? System, designed to improve the EGD and colonoscopy experience and assist in emergent procedures like GI bleeding and the early detection and prevention of colorectal cancer and other diseases of the GI tract. The Pure-Vu? System is a 510(k) U.S. Food and Drug Administration cleared medical device indicated to help facilitate the cleaning of the GI tract during an endoscopy or colonoscopy procedure. The device integrates with gastroscopes and colonoscopes to enable cleaning during the procedure while preserving standard procedural workflow and techniques. The Pure-Vu? System has received CE mark approval in Europe.
Motus GI Medical Technologies的外部链接
Thank you Dr. Reddy and Dr. Samarasena for your commitment to your patients!
We’re happy to announce that Dr.?Shravani Reddy?successfully completed the first procedure at?UCI Health?with our new device. Both staff and physician were pleased with the new device’s ease of use and ability to support a?#GI?bleed case. We would also like to thank Dr.?Jason Samarasena MD MBA AGAF FACG?for his support of our program that helped us get this exciting new product to the market.
We’re happy to announce that Dr.?Shravani Reddy?successfully completed the first procedure at?UCI Health?with our new device. Both staff and physician were pleased with the new device’s ease of use and ability to support a?#GI?bleed case. We would also like to thank Dr.?Jason Samarasena MD MBA AGAF FACG?for his support of our program that helped us get this exciting new product to the market.
We are excited to announce positive results from a European study published in the?UEG - United European Gastroenterology?Journal of the Second Generation Pure-Vu System in improving visualization for #colonoscopy in patients with a history of poor bowel preparation. The positive results from this study further build upon our extensive portfolio of clinical data showing the system’s ability to cleanse the GI tract. This data + the excellent user experiences we’ve been seeing with the latest generation of the Pure-Vu System that recently received FDA clearance = a very exciting future.
We're happy to announce the successful completion of our ISO and EU MDR?audit, with no findings. This achievement signifies our commitment to quality?and management compliance. ?? A special appreciation goes to our dedicated team whose hard work and?support have been instrumental in bringing us one step closer to the?commercialization of our product in the EU. Thank you for your unwavering?dedication.
?? We are pleased to share that our Pure-Vu EVS device has been featured in Endoscopy Journal in a pioneering case study from the Dr. Brian Hanson and team at Minneapolis VA Health Care System. ?? Now with the recent FDA clearance of the Gastro version of Pure-Vu EVS, Upper GI bleeds can routinely use the device to clear the field of view to support doctors and their patients in these emergent procedures. ?? To learn more, read the full paper: https://brnw.ch/21wFDb2
Our lead product is a game-changer. ?? The success of Pure-Vu EVS gives a positive outlook for #UpperGI procedures for physicians and patients alike, especially in emergent situations like a GI bleed. ? Key Features include: Precision Engineering: Our device ensures thorough cleansing, contributing to more accurate endoscopies and better medical outcomes. User-Friendly Design: With an intuitive interface Pure-Vu EVS is easy to use, allowing for increased patient satisfaction. Empowering Healthcare Professionals: Pure-Vu EVS not only benefits patients but also supports healthcare professionals in providing top-notch care. Learn more about the Pure-Vu EVS System: https://brnw.ch/21wFd6X